Clinical Trials Logo

Clinical Trial Summary

Probiotics are favorable microorganisms that regulate the flora of the gastrointestinal system and stimulate the immune system. Lactobacillus reuteri was shown to reduce candida colonization. The objective of this study is to evaluate the efficacy of prophylactic Lactobacillus reuteri in reducing the candida colonization and infection in very low birth weight infants.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT01531192
Study type Interventional
Source Zekai Tahir Burak Women's Health Research and Education Hospital
Contact
Status Completed
Phase Phase 4
Start date June 2012
Completion date April 2013

See also
  Status Clinical Trial Phase
Completed NCT00033917 - Indomethacin Germinal Matrix Hemorrhage/Intraventricular Hemorrhage (GMH/IVH) Prevention Trial Phase 3
Completed NCT02741934 - Cognitive and Behavioral Outcomes of School-aged Children Who Were Born Preterm N/A
Withdrawn NCT00470743 - Comparing Ibuprofen And Indomethacin For The Treatment Of The Patent Ductus Arteriosus in Very Premature Babies Phase 4
Completed NCT02415530 - Early Family Based Intervention in Preterm Infants N/A
Withdrawn NCT03858816 - Efficacy of Multiple Strain Probiotics Reduces the Neurobehavioral Disorder in Premature Very Low Birth Weight Infants N/A
Terminated NCT01434849 - Timolol for the Prevention of Proliferation of Infantile Hemangioma (TiPPIH Trial) Phase 1
Recruiting NCT03876704 - Effects of Fat-soluble Vitamins Supplementation on Common Complications and Neural Development in Very Low Birth Weight Infants Phase 3
Completed NCT01443091 - Oropharyngeal Colostrum for Immune Stimulation in Very Low Birth Weight Infants N/A
Completed NCT02383264 - Splanchnic Oxygenation After the First Enteral Feed in Preterm Infants: Prediction of Feeding Tolerance. N/A
Completed NCT01531179 - Lactobacillus Reuteri for Prevention of Necrotizing Enterocolitis in Very Low-birth Weight Infants Phase 3
Recruiting NCT01315821 - Effect of Saccharomyces Boulardii on Necrotizing Enterocolitis in Very Low Birth Weight Infants Phase 3
Withdrawn NCT00425581 - N-Terminal Pro-B-Type Natriuretic Peptide and Troponin Levels as Markers of Hemodynamic Stability in Very Low Birth Weight Infants During the First Days of Life N/A
Completed NCT01287507 - Lactoferrin Prophylaxis in VLBW and Regulator T-cells N/A
Recruiting NCT02731092 - Safety and Tolerability of Lactoferrin in Very Low Birth Weight Infants Phase 1
Terminated NCT02337088 - Delayed Cord Clamping in Very Low Birth Weight Infants N/A